MedPath

Diphenhydramine

DiphenhydrAMINE Hydrochloride Injection, USP

Approved
Approval ID

fc574e74-1fdc-4a61-a1ed-492ae43faed2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 3, 2019

Manufacturers
FDA

Fresenius Kabi USA, LLC

DUNS: 608775388

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DIPHENHYDRAMINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63323-664
Application NumberANDA040466
Product Classification
M
Marketing Category
C73584
G
Generic Name
DIPHENHYDRAMINE HYDROCHLORIDE
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateOctober 3, 2019
FDA Product Classification

INGREDIENTS (3)

HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
DIPHENHYDRAMINE HYDROCHLORIDEActive
Quantity: 50 mg in 1 mL
Code: TC2D6JAD40
Classification: ACTIB
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Diphenhydramine - FDA Drug Approval Details